Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113755462B reveals high-activity enzyme mutants for chiral beta-amino acid synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112409201B reveals a superior synthesis route for 2-hydroxy-5-[2-(4-(trifluoromethylphenyl)ethylamino)]benzoic acid, ensuring high yield and supply chain stability.
Patent CN103343149B details a low-cost enzymatic route for L-Tyrosine. Discover supply chain advantages and high-purity manufacturing capabilities.
Novel photocatalytic method for deuterated amino acid esters using D2O. High purity, cost-effective, scalable supply for pharmaceutical intermediates and R&D.
Patent CN107904268A reveals enzymatic route for D-cyclic amino acids. Offers high purity, reduced waste, and scalable manufacturing for pharmaceutical intermediates.
Patent CN101874016A details a scalable mesylate-based route for CNS drug intermediates, offering superior purity and cost-effective manufacturing solutions.
Novel acetone-water solvent system for Boc protection. High yield, low cost, scalable process for pharmaceutical intermediates manufacturing.
Novel synthesis of phytosterol phosphorylated amino acid esters offers enhanced solubility and bioavailability for food and pharma applications with scalable production capabilities.
Explore the synthesis of a new substituted ureido methyl benzoate compound. This patent offers a scalable route for high-purity pharmaceutical intermediates targeting diabetes.
Patent CN118724988A reveals a novel glycosylation method enhancing nucleic acid delivery carrier synthesis with improved scalability and purity for pharmaceutical applications.
Patent CN102875426A details a high-purity dansyl acid preparation method offering significant cost reduction and supply chain reliability for fluorescence applications.
Patent CN103130700B reveals a high-yield synthesis route for azelnidipine intermediates. This process ensures high purity and significant supply chain cost advantages.
Patent CN109554406A enables efficient keto acid production. Reduces coenzyme cost and improves supply chain reliability for pharma intermediates.
Novel three-step synthesis for beta-unnatural amino acids. Enhances supply chain stability and reduces manufacturing costs for pharmaceutical intermediates globally.
Patent CN108300744B reveals enzymatic synthesis for high-purity D-heterocyclic amino acids. Discover cost-effective supply chain solutions and scalable manufacturing.
Patent CN1028361C details asymmetric synthesis of 2(S)-glutaric acid intermediates, offering high purity and scalable routes for cardiovascular drug manufacturing.
Patent CN116926139A reveals a novel enzymatic route for N-acetyl-D-amino acid production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110526928A reveals high purity 7-ADCA method. Reduces cost and improves supply chain reliability for API manufacturing significantly.
Patent CN109438270B details a novel esterification method using molecular sieves, offering significant cost reduction and purity improvements for reliable fine chemical intermediate supply chains.
Patent CN104725173A reveals a novel Rhodium-catalyzed asymmetric hydrogenation method for high-purity optically active aldehydes, offering significant cost reduction and supply chain reliability for fragrance manufacturers.